Key result
Atypical antipsychotics and SSRIs had a lower frequency of QTc prolongation than cilostazol and no significant difference versus diazepam.
Why the study?
Do atypical antipsychotic drugs and SSRIs increase the risk of QTc prolongation compared to control drugs in clinical settings?
Observational
Do atypical antipsychotic drugs and SSRIs increase the risk of QTc prolongation compared to control drugs in clinical settings?
Atypical antipsychotics and SSRIs do not appear to significantly increase the risk of QTc prolongation compared to diazepam in a large clinical ECG database.
Answers are grounded in this paper and cite their sources.
May not elevate QTc prolongation risk versus diazepam in real-world ECG data; leaves open randomized confirmation versus cilostazol.
BACKGROUND: This study evaluated the effects of atypical antipsychotic drugs and selective serotonin reuptake inhibitors (SSRIs) on the corrected QT (QTc) interval using a large database obtained from clinical settings. Additionally, the effects of factors including age on QTc intervals were estimated. METHODS: Using an open-access QT database (ECG-ViEW), QTc-lengthening effects of 14 selected atypical antipsychotics and SSRIs were compared to those of a positive control drug, cilostazol, and a negative control drug, diazepam. We also evaluated effects of age, sexgender, and select electrolyte levels on observed QTc intervals. RESULTS: The frequency of QTc prolongation with the pooled data of the 14 study drugs was lower than that with cilostazol (age-adjusted odds ratio (OR) = 0.43, 95% confidence interval (CI) = 0.27-0.69), but no significant difference was found relative to when compared with that with diazepam (age-adjusted OR = 0.89, 95% CI = 0.55-1.47). Furthermore, administration of the 14 study drugs significantly increased the QTc interval by 2.89 ms after each 10-year age increment (p-value < 0.0001). CONCLUSIONS: This study suggests that atypical antipsychotic drugs and SSRIs are less likely to be associated with QTc prolongation in clinical settings. In addition, age showed a significant association with the QTc interval. Further studies with well-characterized cohorts are warranted.
No takes yet. Share an insight, caveat, or question.
Park et al. (2016) conducted an observational in Patients taking atypical antipsychotics or SSRIs. 14 selected atypical antipsychotics and SSRIs vs. Cilostazol (positive control) and diazepam (negative control) was evaluated on Frequency of QTc prolongation (OR 0.43, 95% CI 0.27-0.69). Atypical antipsychotics and SSRIs had a lower frequency of QTc prolongation than cilostazol and no significant difference versus diazepam.
Synapse has enriched 10 related papers. Consider them for comparative context: